Patents by Inventor Zhuowei Hu

Zhuowei Hu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYPEPTIDE, DERIVATIVES THEREOF, AND APPLICATION THEREOF IN PREPARATION OF DRUGS HAVING RESISTANCE TO PULMONARY FIBROSIS
    Publication number: 20210179680
    Abstract: Provided are a polypeptide specifically binding to TRB3 and application thereof in preparation of drugs for treating and/preventing pulmonary fibrosis. The amino acid sequence of the polypeptide is represented by SEQ ID NO:12 in a sequence list, or two or more amino acids in the amino acid sequence as represented by SEQ ID NO:12 in the sequence list are replaced with unnatural amino acids having side chains that can be linked to each other. The polypeptide and derivatives thereof can specifically bind to TRB3, thereby blocking the interaction between TRB3 and MDM2 proteins.
    Type: Application
    Filed: February 24, 2017
    Publication date: June 17, 2021
    Inventor: Zhuowei HU
  • Use of rupatadine in the manufacture of pharmaceutical composition for treating chronic obstructive pulmonary disease
    Patent number: 9241936
    Abstract: Disclosed is the use of rupatadine in the manufacture of pharmaceutical composition for preventing or treating chronic obstructive bronchitis, obstructive emphysema or chronic obstructive pulmonary disease. The new medicament, i.e. rupatadine, for treating chronic obstructive pulmonary disease is obvious in therapeutic effects, and low in toxic and side effects, and safe in use in the aspects of treating chronic obstructive bronchitis, obstructive emphysema or chronic obstructive pulmonary disease.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: January 26, 2016
    Assignee: BEIJING WEIFENG YIMIN BIO-TECHNOLOGY LIMITED COMPANY
    Inventor: Zhuowei Hu
  • Use of Rupatadine in the Manufacture of Pharmaceutical Composition for Treating Chronic Obstructive Pulmonary Disease
    Publication number: 20150018382
    Abstract: Disclosed is the use of rupatadine in the manufacture of pharmaceutical composition for preventing or treating chronic obstructive bronchitis, obstructive emphysema or chronic obstructive pulmonary disease. The new medicament, i.e. rupatadine, for treating chronic obstructive pulmonary disease is obvious in therapeutic effects, and low in toxic and side effects, and safe in use in the aspects of treating chronic obstructive bronchitis, obstructive emphysema or chronic obstructive pulmonary disease.
    Type: Application
    Filed: May 18, 2012
    Publication date: January 15, 2015
    Applicant: Beiging Weifeng Yimin Bio-Technology Limited Company
    Inventor: Zhuowei Hu